These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9972854)

  • 21. Combined treatment with NMDA antagonist, CGP 37849, and sigma receptor agonists, SA4503 or DTG, decreases the neuroleptic-induced catalepsy in rats.
    Skuza G
    Pol J Pharmacol; 2000; 52(4):313-6. PubMed ID: 11345488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The selective sigma(1) receptor agonist, 1-(3,4-dimethoxyphenethyl)-4-(phenylpropyl)piperazine (SA4503), blocks the acquisition of the conditioned place preference response to (-)-nicotine in rats.
    Horan B; Gardner EL; Dewey SL; Brodie JD; Ashby CR
    Eur J Pharmacol; 2001 Aug; 426(1-2):R1-2. PubMed ID: 11525784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the sigma-1 receptor agonist 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)-piperazine dihydro-chloride on inflammation after stroke.
    Ruscher K; Inácio AR; Valind K; Rowshan Ravan A; Kuric E; Wieloch T
    PLoS One; 2012; 7(9):e45118. PubMed ID: 23028794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial effects of acute and repeated administrations of sigma receptor agonists on behavioral despair in mice exposed to tail suspension.
    Ukai M; Maeda H; Nanya Y; Kameyama T; Matsuno K
    Pharmacol Biochem Behav; 1998 Nov; 61(3):247-52. PubMed ID: 9768559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sigma1 and sigma2 receptor binding affinity and selectivity of SA4503 and fluoroethyl SA4503.
    Lever JR; Gustafson JL; Xu R; Allmon RL; Lever SZ
    Synapse; 2006 May; 59(6):350-8. PubMed ID: 16463398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo evaluation of [(11)C]SA4503 as a PET ligand for mapping CNS sigma(1) receptors.
    Kawamura K; Ishiwata K; Tajima H; Ishii S; Matsuno K; Homma Y; Senda M
    Nucl Med Biol; 2000 Apr; 27(3):255-61. PubMed ID: 10832082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The sigma agonist 1,3-di-o-tolyl-guanidine directly blocks SK channels in dopaminergic neurons and in cell lines.
    Lamy C; Scuvée-Moreau J; Dilly S; Liégeois JF; Seutin V
    Eur J Pharmacol; 2010 Sep; 641(1):23-8. PubMed ID: 20546722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of sigma, PCP, and opiate receptor ligands in rats trained with ibogaine as a discriminative stimulus.
    Helsley S; Filipink RA; Bowen WD; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 1998 Feb; 59(2):495-503. PubMed ID: 9477000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute and chronic administration of the selective sigma1 receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study.
    Minabe Y; Matsuno K; Ashby CR
    Synapse; 1999 Aug; 33(2):129-40. PubMed ID: 10400891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of sigma ligands on the cocaine-induced convulsions in mice.
    Skuza G
    Pol J Pharmacol; 1999; 51(6):477-83. PubMed ID: 10817525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo functional interaction between phencyclidine binding sites and sigma receptors to produce head-weaving behavior in rats.
    Kitaichi K; Noda Y; Hasegawa T; Furukawa H; Nabeshima T
    Eur J Pharmacol; 1996 Dec; 318(2-3):205-11. PubMed ID: 9016907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-related changes of the binding of [3h]SA4503 to sigma1 receptors in the rat brain.
    Ishiwata K; Kobayashi T; Kawamura K; Matsuno K
    Ann Nucl Med; 2003 Feb; 17(1):73-7. PubMed ID: 12691135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biperiden hydrochlorate ameliorates dystonia of rats produced by microinjection of sigma ligands into the red nucleus.
    Yoshida K; Takahashi H; Sato K; Higuchi H; Shimizu T
    Pharmacol Biochem Behav; 2000 Nov; 67(3):497-500. PubMed ID: 11164078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SA4503, a novel cognitive enhancer, with sigma 1 receptor agonistic properties.
    Matsuno K; Senda T; Kobayashi T; Okamoto K; Nakata K; Mita S
    Behav Brain Res; 1997 Feb; 83(1-2):221-4. PubMed ID: 9062689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The synergistic effect of selective sigma receptor agonists and uncompetitive NMDA receptor antagonists in the forced swim test in rats.
    Skuza G; Rogóz Z
    J Physiol Pharmacol; 2006 Jun; 57(2):217-29. PubMed ID: 16845227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and evaluation of 11C- and 18F-labeled 1-[2-(4-alkoxy-3-methoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazines as sigma receptor ligands for positron emission tomography studies.
    Kawamura K; Elsinga PH; Kobayashi T; Ishii S; Wang WF; Matsuno K; Vaalburg W; Ishiwata K
    Nucl Med Biol; 2003 Apr; 30(3):273-84. PubMed ID: 12745019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of SA4503, a novel sigma1 receptor agonist, against glutamate neurotoxicity in cultured rat retinal neurons.
    Senda T; Mita S; Kaneda K; Kikuchi M; Akaike A
    Eur J Pharmacol; 1998 Jan; 342(1):105-11. PubMed ID: 9544798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sigma sites mediate DTG-evoked hypothermia in rats.
    Rawls SM; Baron DA; Geller EB; Adler MW
    Pharmacol Biochem Behav; 2002 Nov; 73(4):779-86. PubMed ID: 12213522
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.